Diflucan® Partnership Program

Through the Diflucan® Partnership Program, Pfizer’s antifungal medicine Diflucan® (fluconazole) is made available free of charge for the treatment of cryptococcal meningitis and esophageal candidiasis, two opportunistic infections associated with HIV/AIDS, to governments and nongovernmental organizations in developing countries. Countries with HIV/AIDS prevalence greater than 1 percent are given priority.

Governments and nongovernmental organizations may apply to the Diflucan® Partnership Program by submitting an application. See a list of eligible countries in the Diflucan® Partnership Program.

Diflucan® for donation is available in the following dosage forms: 200 mg tablets (pink in color), 200 mg intravenous vials and 50 mg/5 ml powder for oral suspension for pediatric use. The Diflucan® Partnership Program also provides information for health professionals on the diagnosis and treatment of cryptococcal meningitis and esophageal candidiasis. Access the training module here.

The prescription and use of Diflucan® requires the donated product to be registered in the country of use. If these dosage forms and indications of Diflucan® are not registered, the applying organization must secure a special import license, waiver, or other documentation required by the government of the country to receive the donation.

The Diflucan® Partnership offers Diflucan® free of charge and will cover the shipping costs up to the point of entry in the country. The recipient is responsible for all other charges, including costs of handling, taxes and duties, and distribution in the country.

Diflucan Partnership Program Distribution MapDiflucan Partnership Program Distribution Map
In celebration of World AIDS Day 2012, Direct Relief released the Diflucan Partnership Program Map, an interactive map that highlights the significant achievements made by Diflucan Partnership Program since 2000. The map illustrates the nearly 90 million defined daily doses of Diflucan that have been distributed to people living with HIV in 60 countries in sub-Saharan Africa, Asia, and Latin America.

About the Partners
Pfizer Inc, a worldwide biopharmaceutical company, manufactures Diflucan® and donates it to Direct Relief International. A nonprofit medical aid organization, Direct Relief International processes the applications, maintains databases, and monitors re-ordering for the applicant organizations.

Contact & Copyright

© 2001-2014 Direct Relief. All rights reserved.
Direct Relief is a registered 501(c)(3) organization.
Direct Relief
27 S. La Patera Lane
Santa Barbara, CA 93117
Phone: (805) 964-4767
Fax: (805) 681-4838
Federal Tax ID number: 95-1831116
Email & Contact Form
Privacy Policy | Donation Policy

Awards & Recognition